Advertisement

Fenwal wins FDA 510(k) clearance Alyx system software version 3.1 for plasma collection.

Fenwal lands 510(k) clearance for Alyx blood collection software

Fenwal Inc. said it landed 510(k) clearance from the FDA for a new version of software for its Alyx blood collection system.

Lake Zurich, Ill.-based Fenwal, a subsidiary of Fresenius (NYSE:FMS), said the new software adds a protocol for closed-system plasma collection and expanded data management capacity.

The new Alyx software also supports remote procedure setup and paperless documentation when used with the Fenwal DXT Relay data exchange software and a blood center’s blood establishment computer system, according to a press release.

Advertisement
Advertisement